Company Filing History:
Years Active: 2010-2011
Title: Marie-Odile Galcera-Contour: Innovator in Cancer Treatment
Introduction
Marie-Odile Galcera-Contour is a prominent inventor based in Bondoufle, France. She has made significant contributions to the field of cancer treatment through her innovative research and development of novel compounds. With a total of 2 patents, her work focuses on inhibitors of cdc phosphatases, which play a crucial role in cancer therapy.
Latest Patents
Her latest patents include groundbreaking inventions that target cdc25 phosphatases. The first patent describes novel compounds comprising 2 or 3 benzothiazole-4,7-dione- or benzooxazole-4,7-dione-type units. These compounds are designed to inhibit cdc25-C phosphatase, which is particularly relevant in the treatment of cancer. The second patent focuses on 4,7-dioxobenzothiazole-2-carboxamide derivatives, which also inhibit cdc25 phosphatases, specifically cdc25-C phosphatase, and can be utilized in cancer treatment.
Career Highlights
Marie-Odile Galcera-Contour is currently associated with Ipsen Pharma S.a.s., where she continues her research and development efforts. Her work has been instrumental in advancing therapeutic options for cancer patients.
Collaborations
She collaborates with notable colleagues, including Grégoire Prevost and Alban Sidhu, to further enhance the impact of her research in the pharmaceutical industry.
Conclusion
Marie-Odile Galcera-Contour's innovative contributions to cancer treatment through her patents highlight her role as a leading inventor in the field. Her work continues to pave the way for new therapeutic approaches that can significantly benefit patients.